| Becloneb 400 micrograms/1 ml nebuliser suspension PA0584/003/001 |
Beclometasone dipropionate |
Chiesi Farmaceutici S.p.A. |
Not marketed |
| Becloneb 800 micrograms/2 ml nebuliser suspension PA0584/003/002 |
Beclometasone dipropionate |
Chiesi Farmaceutici S.p.A. |
Not marketed |
| Beclospin 400 micrograms/1 ml nebuliser suspension PA0584/004/001 |
Beclometasone dipropionate anhydrous |
Chiesi Farmaceutici S.p.A. |
Not marketed |
| Beclospin 800 micrograms/2 ml nebuliser suspension PA0584/004/002 |
Beclometasone dipropionate |
Chiesi Farmaceutici S.p.A. |
Not marketed |
| Bramitob 300mg/4ml Nebuliser Solution PA0584/007/001 |
Tobramycin |
Chiesi Farmaceutici S.p.A. |
Marketed |
| Clenil Modulite 100 micrograms per metered dose Pressurised Inhalation Solution PA0584/006/002 |
Beclometasone dipropionate |
Chiesi Farmaceutici S.p.A. |
Not marketed |
| Clenil Modulite 200 micrograms per metered dose Pressurised Inhalation Solution PA0584/006/003 |
Beclometasone dipropionate |
Chiesi Farmaceutici S.p.A. |
Not marketed |
| Clenil Modulite 250 micrograms per metered dose Pressurised Inhalation Solution PA0584/006/004 |
Beclometasone dipropionate |
Chiesi Farmaceutici S.p.A. |
Not marketed |
| Clenil Modulite 50 micrograms per metered dose Pressurised Inhalation Solution PA0584/006/001 |
Beclometasone dipropionate |
Chiesi Farmaceutici S.p.A. |
Not marketed |
| CUROSURF 120 mg/vial Endotracheopulmonary instillation, suspension PA0584/005/001 |
Porcine lung surfactant |
Chiesi Farmaceutici S.p.A. |
Marketed |
| CUROSURF 240 mg/vial Endotracheopulmonary instillation, suspension PA0584/005/002 |
Porcine lung surfactant |
Chiesi Farmaceutici S.p.A. |
Marketed |
| Elfabrio 2 mg/ml Concentrate for solution for infusion EU/1/23/1724/001-003 |
Pegunigalsidase Alfa |
Chiesi Farmaceutici S.p.A. |
— |
| Envarsus 0.75 mg prolonged-release tablets EU/1/14/35/001-003 |
Tacrolimus monohydrate |
Chiesi Farmaceutici S.p.A. |
— |
| Envarsus 1 mg prolonged-release tablets EU/1/14/35/004-006 |
Tacrolimus monohydrate |
Chiesi Farmaceutici S.p.A. |
— |
| Envarsus 4 mg prolonged-release tablets EU/1/14/35/007-009 |
Tacrolimus monohydrate |
Chiesi Farmaceutici S.p.A. |
— |
| Ferriprox 1 000 mg film-coated tablets EU/1/99/108/004-006 |
Deferiprone |
Chiesi Farmaceutici S.p.A. |
— |
| Ferriprox 100 mg/ml oral solution EU/1/99/108/002-003 |
Deferiprone |
Chiesi Farmaceutici S.p.A. |
— |
| Ferriprox 500 mg film-coated tablets EU/1/99/108/001 |
Deferiprone |
Chiesi Farmaceutici S.p.A. |
— |
| Filsuvez EU/1/22/1652/001-002 |
BETULAE CORTEX DRY EXTRACT (5-10 : 1); EXTRACTION SOLVENT: N-HEPTANE 95% (W/W) |
Chiesi Farmaceutici S.p.A. |
— |
| Fostair 100 microgram/6 microgram per actuation pressurised inhalation solution PA0584/008/001 |
Beclometasone dipropionate, Formoterol fumarate dihydrate |
Chiesi Farmaceutici S.p.A. |
Not marketed |
| Fostair 200 microgram/6 microgram per actuation pressurised inhalation solution PA0584/008/003 |
Beclometasone dipropionate, Formoterol fumarate dihydrate |
Chiesi Farmaceutici S.p.A. |
Not marketed |
| Fostair Nexthaler 100 micrograms/6 micrograms per metered dose inhalation powder PA0584/008/002 |
Beclometasone dipropionate, Formoterol fumarate dihydrate |
Chiesi Farmaceutici S.p.A. |
Not marketed |
| Fostair Nexthaler 200 micrograms/6 micrograms per metered dose inhalation powder PA0584/008/004 |
Formoterol fumarate dihydrate, Beclometasone dipropionate anhydrous |
Chiesi Farmaceutici S.p.A. |
Not marketed |
| Kengrexal 50 mg powder for concentrate for solution for injection/infusion EU/1/15/994/001 |
Cangrelor tetrasodium |
Chiesi Farmaceutici S.p.A. |
— |
| Lamzede 10 mg powder for solution for infusion EU/1/17/1258/001-003 |
Velmanase alfa |
Chiesi Farmaceutici S.p.A. |
— |
| Lojuxta 10 mg hard capsules EU/1/13/851/002 |
Lomitapide mesylate |
Chiesi Farmaceutici S.p.A. |
— |
| Lojuxta 20 mg hard capsules EU/1/13/851/003 |
Lomitapide mesylate |
Chiesi Farmaceutici S.p.A. |
— |
| Lojuxta 30 mg hard capsules EU/1/13/851/004 |
Lomitapide mesylate |
Chiesi Farmaceutici S.p.A. |
— |
| Lojuxta 40 mg hard capsules EU/1/13/851/005 |
Lomitapide mesylate |
Chiesi Farmaceutici S.p.A. |
— |
| Lojuxta 5 mg hard capsules EU/1/13/851/001 |
Lomitapide mesylate |
Chiesi Farmaceutici S.p.A. |
— |
| Lojuxta 60 mg hard capsules EU/1/13/851/006 |
Lomitapide mesylate |
Chiesi Farmaceutici S.p.A. |
— |
| Myalepta 11.3 mg powder for solution for injection EU/1/18/1276/001-002 |
Metreleptin |
Chiesi Farmaceutici S.p.A. |
— |
| Peyona 20 mg/mL solution for infusion and oral solution EU/1/09/528/001 |
Caffeine citrate |
Chiesi Farmaceutici S.p.A. |
— |
| PROCYSBI 25 mg gastro-resistant hard capsules EU/1/13/861/001 |
Cysteamine bitartrate |
Chiesi Farmaceutici S.p.A. |
— |
| PROCYSBI 300 mg gastro-resistant granules EU/1/13/861/004 |
Mercaptamine bitartrate |
Chiesi Farmaceutici S.p.A. |
— |
| PROCYSBI 75 mg gastro-resistant granules EU/1/13/861/003 |
Mercaptamine bitartrate |
Chiesi Farmaceutici S.p.A. |
— |
| PROCYSBI 75 mg gastro-resistant hard capsules EU/1/13/861/002 |
Cysteamine bitartrate |
Chiesi Farmaceutici S.p.A. |
— |
| Quinsair 240mg Nebuliser solution EU/1/14/973/001 |
Levofloxacin |
Chiesi Farmaceutici S.p.A. |
— |
| Raxone 150 mg film-coated tablets EU/1/15/1020/001 |
Idebenone |
Chiesi Farmaceutici S.p.A. |
— |
| Trimbow EU/1/17/1208/004 |
Glycopyrronium bromide, Formoterol fumarate dihydrate, Beclometasone dipropionate |
Chiesi Farmaceutici S.p.A. |
— |
| Trimbow EU/1/17/1208/005 |
Beclometasone dipropionate, Glycopyrronium bromide, Formoterol fumarate dihydrate |
Chiesi Farmaceutici S.p.A. |
— |
| Trimbow 172 micrograms/5 micrograms/9 micrograms pressurised inhalation, solution EU/1/17/1208/006-009 |
Beclometasone dipropionate, Formoterol fumarate dihydrate, Glycopyrronium bromide |
Chiesi Farmaceutici S.p.A. |
— |
| Trimbow 87 micrograms/5 micrograms/9 micrograms pressurised inhalation, solution EU/1/17/1208/001-003 |
Beclometasone dipropionate, Formoterol fumarate dihydrate, Glycopyrronium bromide |
Chiesi Farmaceutici S.p.A. |
— |
| Trimbow 88 micrograms/5 micrograms/9 micrograms inhalation powder EU/1/17/1208/010-012 |
Beclometasone dipropionate, Formoterol fumarate dihydrate, GLYCOPYRRONIUM, Glycopyrronium bromide |
Chiesi Farmaceutici S.p.A. |
— |
| Trydonis 87 micrograms/5 micrograms/9 micrograms pressurised inhalation, solution EU/1/18/1274/001-005 |
Beclometasone dipropionate, Formoterol fumarate dihydrate, GLYCOPYRRONIUM |
Chiesi Farmaceutici S.p.A. |
— |
| Trydonis 88 micrograms/5 micrograms/9 micrograms inhalation powder EU/1/18/1274/006-008 |
Beclometasone dipropionate, Formoterol fumarate dihydrate, Glycopyrronium bromide |
Chiesi Farmaceutici S.p.A. |
— |